Innovative Approaches in Migraine Prevention: Insights from Recent Research

This chapter explores the phase two study findings of a monoclonal antibody targeting PACAP in migraine prevention, highlighting the efficacy and safety compared to a placebo. It also discusses the necessity for new preventive treatments, reported adverse effects, and outlines potential directions for future research.